The Efficacy and Safety of Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Nasopharyngeal Carcinoma: Literature-based Meta-analyses

Background: Anti-epidermal growth factor receptor monoclonal antibodies (anti-EGFR mAbs), such as cetuximab and nimotuzumab have been used in the treatment of nasopharyngeal carcinoma (NPC), yet their efficacy and safety are undetermined. Materials and Methods: We performed two meta-analyses based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Liang, Liu, Ze-Long, Xu, Cheng, Tang, Ling-Long, Liu, Xu, Lin, Ai-Hua, Sun, Ying, Chen, Yu-Pei, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277641/
https://www.ncbi.nlm.nih.gov/pubmed/30519357
http://dx.doi.org/10.7150/jca.27611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277641/
https://www.ncbi.nlm.nih.gov/pubmed/30519357
http://dx.doi.org/10.7150/jca.27611

Ejemplares similares